INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO)
CUSIP: 45773H409
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 66,777,963
- Total 13F shares
- 20,711,886
- Share change
- +10,542,179
- Total reported value
- $48,449,935
- Put/Call ratio
- 10%
- Price per share
- $2.34
- Number of holders
- 98
- Value change
- +$25,433,512
- Number of buys
- 45
- Number of sells
- 55
Quarterly Holders Quick Answers
What is CUSIP 45773H409?
CUSIP 45773H409 identifies INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45773H409:
Top shareholders of INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Adage Capital Management, L.P. |
13D/G
|
— |
10%
|
5,517,650
|
$12,911,301 | $0 | 30 Sep 2025 | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13D/G
|
— |
9.2%
|
3,633,333
|
$6,794,333 | $0 | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3%
|
2,009,145
|
$4,088,610 | — | 30 Jun 2025 | |
| Deep Track Capital, LP |
13F
13D/G
|
Company |
2.4%
from 13D/G
|
1,981,370
|
$4,032,088 | — | 30 Jun 2025 | |
| Stonepine Capital Management, LLC |
13D/G
|
— |
3.8%
|
1,434,997
|
$2,683,444 | -$900,721 | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.9%
|
1,270,607
|
$2,585,685 | — | 30 Jun 2025 | |
| Jong Joseph Kim |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
3,113,086
mixed-class rows
|
$2,451,149 | — | 11 Mar 2022 | |
| BlackRock, Inc. |
13D/G
13F
|
Company |
1.5%
|
537,627
|
$1,099,608 | -$3,642,379 | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.66%
|
437,549
|
$890,622 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.6%
|
401,862
|
$817,792 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.52%
|
346,865
|
$705,870 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.49%
|
328,129
|
$667,743 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.38%
|
254,425
|
$517,755 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.3%
|
199,679
|
$406,348 | — | 30 Jun 2025 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.26%
|
171,561
|
$349,127 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.25%
|
168,956
|
$343,825 | — | 30 Jun 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.24%
|
163,260
|
$332,000 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.23%
|
151,267
|
$307,828 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.2%
|
136,774
|
$278,335 | — | 30 Jun 2025 | |
| GMT CAPITAL CORP |
13F
|
Company |
0.19%
|
126,119
|
$256,652 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.19%
|
123,610
|
$251,546 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.18%
|
122,213
|
$249,000 | — | 30 Jun 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.17%
|
115,164
|
$234,359 | — | 30 Jun 2025 | |
| FMR LLC |
13F
|
Company |
0.13%
|
87,344
|
$177,745 | — | 30 Jun 2025 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0.12%
|
80,000
|
$162,800 | — | 30 Jun 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.11%
|
72,727
|
$147,999 | — | 30 Jun 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.11%
|
72,222
|
$146,000 | — | 30 Jun 2025 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.09%
|
57,946
|
$117,920 | — | 30 Jun 2025 | |
| Concurrent Investment Advisors, LLC |
13F
|
Company |
0.08%
|
56,011
|
$113,982 | — | 30 Jun 2025 | |
| Green Alpha Advisors, LLC |
13F
|
Company |
0.08%
|
53,308
|
$108,482 | — | 30 Jun 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.08%
|
53,171
|
$108,204 | — | 30 Jun 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.06%
|
42,917
|
$87,336 | — | 30 Jun 2025 | |
| Y-Intercept (Hong Kong) Ltd |
13F
|
Company |
0.06%
|
42,171
|
$85,818 | — | 30 Jun 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.06%
|
40,456
|
$82,446 | — | 30 Jun 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.06%
|
39,683
|
$80,755 | — | 30 Jun 2025 | |
| Virtu Financial LLC |
13F
|
Company |
0.06%
|
38,482
|
$78,000 | — | 30 Jun 2025 | |
| Jain Global LLC |
13F
|
Company |
0.06%
|
37,601
|
$76,518 | — | 30 Jun 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.05%
|
32,572
|
$66,284 | — | 30 Jun 2025 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.04%
|
26,075
|
$55,930 | — | 30 Jun 2025 | |
| Simon X. Benito |
3/4/5
|
Director |
—
mixed-class rows
|
17,275
mixed-class rows
|
$51,120 | — | 21 May 2025 | |
| Wendy L. Yarno |
3/4/5
|
Director |
—
mixed-class rows
|
15,596
mixed-class rows
|
$47,980 | — | 21 May 2025 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.03%
|
23,003
|
$46,811 | — | 30 Jun 2025 | |
| Ann C. Miller |
3/4/5
|
Director |
—
mixed-class rows
|
14,961
mixed-class rows
|
$46,792 | — | 21 May 2025 | |
| Jay Shepard |
3/4/5
|
Director |
—
mixed-class rows
|
14,293
mixed-class rows
|
$45,543 | — | 21 May 2025 | |
| Roger D. Dansey |
3/4/5
|
Director |
—
mixed-class rows
|
14,000
mixed-class rows
|
$44,995 | — | 21 May 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.03%
|
22,038
|
$44,847 | — | 30 Jun 2025 | |
| Lota S. Zoth |
3/4/5
|
Director |
—
mixed-class rows
|
13,810
mixed-class rows
|
$44,640 | — | 21 May 2025 | |
| NOMURA HOLDINGS INC |
13F
|
Company |
0.03%
|
20,987
|
$42,709 | — | 30 Jun 2025 | |
| Prime Capital Investment Advisors, LLC |
13F
|
Company |
0.03%
|
20,372
|
$41,457 | — | 30 Jun 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
18,000
|
$36,630 | — | 30 Jun 2025 |
Institutional Holders of INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO) as of Q3 2025
As of 30 Sep 2025,
INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO) was held by
98 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,711,886 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP, L.L.C., JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, Boxer Capital Management, LLC, MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, D. E. Shaw & Co., Inc., MORGAN STANLEY, BANK OF AMERICA CORP /DE/, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
98
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
101
Q3 2025 holders
98
Holder diff
-3
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.